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Background: It has been demonstrated that the incidence of trigeminal neuralgia in elderly patients is higher and
thus, neurosurgeons often encounter elderly patients with this disorder. However, for those with poor basic condition,
the optimal surgical treatment remains controversial. In this study, the authors aimed to evaluate the safety and efficacy
of percutaneous balloon compression (PBC) for primary trigeminal neuralgia in elderly patients older than 80 years.
Methods: From September 2009 to March 2013, a total of 68 patients older than 80 years underwent PBC, and a
retrospective study of the clinical data of these patients was performed.
Results: After PBC, pain relief was immediate in 66 (97.0 %) patients, 1 (1.5 %) patient had no pain relief, and 1 (1.5 %)
patient had some pain that could be controlled with medication. With a mean length of follow-up of 40.1 months,
ranging from 24 to 66 months after surgery, 55 (80.9 %) patients were still pain free. Of the 11 patients with recurrence,
9 cases had mild recurrence and 2 cases suffered severe recurrence. The mean time to recurrence was 18.9 months
(1–64 months). Postoperative morbidity included common side effects such as facial numbness in 66 (97.1 %) patients,
masseter muscle weakness in 19 (27.9 %) patients, paresthesia in 7 (10.3 %) patients, and diplopia secondary to
abducens nerve weakness in 1 (1.5 %) patient. No corneal anesthesia, subarachnoid hemorrhage, or other serious
surgical complications occurred in this study.
Conclusions: In this study, the authors reviewed data on a cohort of patient older than 80 years. The PBC procedure
has advantages in that it is minimally invasive, safe, effective, and could be performed under general anesthesia. This
makes it an optimized choice for elderly patients.
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Trigeminal neuralgia is a disorder characterized by sharp
and paroxysmal pain within the trigeminal nerve distribu-
tion. With the aging population, the proportion of elderly
patients is gradually increased [1]. The etiology of trigemi-
nal neuralgia is still controversial. Since Jannetta [2] refined
and popularized microvascular decompression (MVD), it
has become the first-line choice [3, 4], but it is nonetheless
associated with some special risks such as cranial nerve in-
jury, cerebellar hematoma, stroke, and death which are not* Correspondence: d542762345@126.com
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for the elderly patients older than 80 years, whether or not
performing MVD is still controversial [5–7]. Percutaneous
balloon compression (PBC) was first described by Mullan
and Lichtor [8] in 1983. Because PBC is a minimally inva-
sive, low-cost, safe, and effective procedure and could be
simply performed with the patient under general
anesthesia, it has become increasingly popular around
the world. It has also been reported to provide longer
pain relief than the other two percutaneous proce-
dures and stereotactic radiosurgery (SRS) [4].
By now, no analysis regarding PBC for elderly patients
has been reported. In this study, we aimed to evaluate
the safety and efficacy of PBC for primary trigeminal
neuralgia in elderly patients older than 80 years.istributed under the terms of the Creative Commons Attribution 4.0
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Patients
In this study, all patients had been approved by the
appropriate ethics and we obtained informed patient
consent. From September 2009 to March 2013, a total
of 73 patients older than 80 years underwent PBC at
the Department of Neurosurgery in the Hangzhou
First People’s Hospital. Four patients died for other
reasons and one patient was lost to follow-up, so
these five patients were excluded in this study. The
demographic characteristics of these 68 patients are
summarized in Table 1. The patients (38 women and
30 men) were aged between 80 and 92 years; the
mean age was 84.5 years. Second combined with third
division was the most common condition, affecting 29
(42.6 %) patients, followed by the third and second
division in 15 (22.1 %) patients and 13 (19.1 %) pa-
tients, respectively. The right side was affected in 39
patients, while the left side in the other 29. Of these
68 patients, 28 patients had one or more prior surgi-
cal treatment. Before PBC, all patients had received
medical treatment such as carbamazepine, oxcarbaze-
pine, gabapentin, and so on and were refractory or
intolerant to the medical treatment. Prior to the sur-
gical procedure, they also had a CT or MR imaging
to exclude secondary trigeminal neuralgia.Table 1 The demographic characteristics of these 68 patients
Age, year (range) 84.5 (80–92)
Sex (M:F), no 30:38
Disease duration, year (range) 12.3 (3–45)
Pain involvement, no (%)
V1 3 (4.4 %)
V2 13 (19.1 %)
V3 15 (22.1 %)
V1 + V2 6 (8.8 %)
V2 + V3 29 (42.6 %)
V1 + V2 + V3 2 (2.9 %)
Side affected, no (%)
Left side 29 (42.6 %)
Right side 39 (57.4 %)
Clinical subtypes, no (%)
Typical 62 (91.2 %)
Atypical 6 (8.8 %)




Alcohol blocks 12Surgical technique
The method we used was in accordance with the tech-
nique first described by Mullan and Lichtor [8] with modi-
fication. All PBCs were performed under a short-acting
general anesthesia. During operation, the heart rate, ECGs,
and blood pressure of the patients were closely monitored.
The patients were placed in the supine position on the
operating table, with slight extension and approximately
30° of rotation of the neck away from the ill side. The pro-
cedure was performed using C-arm image intensifier
fluoroscope in order to obtain lateral images and location.
The entry point was positioned at about 2.5 cm lateral to
commissure of the lips, and the other two reference points
were 3 cm anterior to the external auditory meatus along
the zygomatic arch, and 1 cm inferior to the pupil and. A
14-gauge needle containing a blunt obturator was ad-
vanced until it penetrated the foramen ovale under lateral
fluoroscopic imaging. The blunt obturator was then with-
drawn, and a no. 4 Fogarty balloon catheter with a stain-
less steel stylet was advanced into Meckel’s cave under
direct fluoroscopy. Then, the stylet was withdrawn. Under
fluoroscopic control, the balloon was slowly inflated by
adding undiluted contrast Omnipaque (300 mg iodine/
mL) until it was proximal to the posterior fossa. Referring
to the bony landmarks (clivus, sella, and petrous bones),
the balloon shape and position were inspected. If neces-
sary, the balloon was deflated and the catheter was reposi-
tioned until a pear-shaped balloon with a protrusion
towards the posterior fossa was obtained. The balloon vol-
ume of this study was between 0.45 and 0.85 mL (depend-
ing on the individual’s volume of Meckel’s cave), and
balloon compression time was between 3 and 8 min. After
compression, the balloon was deflated, withdrawn with
the catheter. The puncture wound was compressed for
about 5 min. The total procedure usually lasted for less
than 20 min.
Follow-up and effect evaluation
Postoperative data were obtained by independent neuro-
surgeon by telephone or in the outpatient clinic. Four
patients died for other reasons and one patient was lost
to follow-up, so these five patients were excluded in this
study. Assessment of result is based on Barrow Neuro-
logical Institute (BNI) pain intensity scale score (Table 2).
Mild recurrence is defined as BNI pain score increased
from I to II–III during the postoperative period. Severe
recurrence was defined as BNI pain score increased from
I to IV–V.
Results
The results of these 68 patients are summarized in Table 3.
After PBC, pain relief was immediate in 66 (97.0 %)
patients (BNI I), 1 (1.5 %) patient had no pain relief (BNI
V), and 1 (1.5 %) patient had some pain (BNI III) that
Table 2 Barrow Neurological Institute (BNI) pain intensity scale
score
Score Definition
I No pain, no medication
II Occasional pain, not requiring medication
III Some pain, adequately controlled with medication
IV Some pain, not adequately controlled with medication
V Severe pain/no pain relief
Table 4 The complications of the 68 patients after PBC
Complications Cases (%)
Facial numbness 66 (97.1)
Masseter muscle weakness 19 (27.9)
Paresthesia 7 (10.3)
Diplopia 1 (1.5)
Herpes simplex 27 (39.7)
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of follow-up of 40.1 months, ranging from 24 to 66
months after surgery, 55 (80.9 %) patients were still pain
free (BNI I). Of the 11 patients with recurrence, 9 cases
had mild recurrence and 2 cases suffered severe recur-
rence. The mean time to recurrence was 18.9 months (1–
64 months).
Postoperative morbidity was listed in Table 4. As ex-
pected, facial numbness was the most common mor-
bidity, occurred in 66 (97.1 %) patients, but most of
them could tolerate it well. Masseter muscle weakness
affected 19 (27.9 %) patients; most of them recovered
within 12 months after operation. One (1.5 %) patient
suffered diplopia secondary to abducens nerve weak-
ness and recovered within 4 months. Twenty-seven
(39.7 %) patients had herpes simplex after PBC, and
the symptoms lasted within 2 weeks. Paresthesia oc-
curred in 7 (10.3 %) patients. No corneal anesthesia,
subarachnoid hemorrhage, or other serious surgical
complications occurred in this study.
Discussion
Trigeminal neuralgia is a disorder which has a tendency
to occur in the older patients [1], with a mean age of
51.5 years at diagnosis [9]. With the aging population,
the proportion of elderly patients has gradually increased
[1]. Since Jannetta [2] refined and popularized MVD, it
has become the first-line choice [3, 4], but it is nonethe-
less associated with some special risks such as cranial
nerve injury, cerebellar hematoma, stroke, and death
which are not seen with the commonly performed abla-
tive procedures. Many authors have reported the safety
and efficacy for the elderly patients treated with MVD.Table 3 The outcomes of the 68 patients after PBC





number of patients (%)
I 66 (97.0) 55 (80.9)
II 0 3 (4.4)
III 1 (1.5) 7 (10.3)
IV 0 1 (1.5)
V 1 (1.5) 2 (2.9)The age cutoffs range from 60 to 75 years [10–15]. So
for the elderly patients older than 80 years, MVD is still
controversial [5–7]. Yang et al. [15] reported outcomes
on 59 patients older than 65 years, and they found that
the acute pain relief after surgery was 93.2 % and the re-
currence rate was 8.9 % with a mean length of follow-up
of 42 months. Complications after surgery included
headaches, nausea, and vomiting; there were no severe
morbidities and mortalities. Günther et al. [11] reported
the results of 112 patients older than 65 years (mean
70.35 years), the pain-free and recurrence rate were 75
and 14 %, respectively, with a mean length of follow-up
of 90 months, and complications included hypesthesia in
6.25 % of the patients, hypacusis in 5.4 % of patients,
and partial facial nerve palsy, complete hearing loss, and
vertigo in 0.89 % each. One patient suffered meningitis
and cerebrospinal fluid leak [11]. In Sekula et al.’s report
[14], the acute pain relief was achieved in 96 % of the 25
patients older than 75 years, with an average follow-up
of 44 months; 78 % of the patients remained pain free.
So far, several published studies [10–15] suggested that
the safety and efficacy of MVD in elderly patients have
no difference with the younger ones. But these studies
were small sample sizes, and Sekula et al. summarized
these studies in a meta-analysis [16]. Ruqhani et al. [17]
utilized a large national data set and found that the risk
of pulmonary, cardiac, cerebrovascular, and thrombo-
embolic complications was higher in older patients. So
for the elderly patients, MVD remains a controversial
surgical option, and postoperative morbidities do tend to
gradually increase in tandem with an advanced age [17].
So gamma knife or percutaneous procedures might be
the first surgical option for the elderly patients with poor
fitness.
PBC was first described by Mullan and Lichtor [8] in
1983. Because PBC is a minimally invasive, low-cost,
safe, and effective procedure and could be simply per-
formed with the patient under general anesthesia, it has
become increasingly popular around the world. It has
also been reported to provide longer pain relief than the
other two percutaneous procedures and SRS [4]. Several
studies [4, 8, 17–23] had proved the safety and efficacy
of PBC. In their 20-year follow-up study of 496 patients,
Skirving and Dan [19] reported that the acute pain relief
was 99.8 %, recurrence rate was 19.2 % within 5 years,
Table 5 Postoperative complications of PBC series (%)
Series Facial numbness Masseter muscle weakness Dysesthesia Anesthesia dolorosa Corneal anesthesia Diplopia Meningitis
Brown et al. 77 16 3.5 0 0 0.7 5
Skirving et al. 89 3.4 3.8 0 0 1.6 0
Stomal et al. >90 11.9 1.7 1.7 0 3.4 0
Chen et al. 100 18.8 a 0 15.6 0 0
Campos et al. a 17.9 10.3 0 2.6 2.6 0
aNot clear
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years. Baabor and Perez-Limonte [22] reported the out-
comes on 206 patients; the initial pain relief was 93 %,
and the recurrence rate was 15 % after a 3-year follow-
up. Lichtor and Mullan [23] reported their experience
on 100 patients; the successful rate was 97 %, and the re-
currence rate was 20 % for 5 years. In the present study,
we found that the pain relief was immediate in 97.0 % of
the patients, with a mean length of follow-up of 40.1
months; 80.9 % of the patients were still pain free. Our
efficacy was similar with the published studies. Nine
cases had mild recurrence; of these, three cases did not
require medication, six cases could adequately be con-
trolled with medication, and most of them were satisfied
with the results. PBC was repeated a second time in the
two patients who suffered severe recurrence.
As expected preoperatively, numbness and transient
masseter muscle weakness were the two most common
complications, affecting 66 patients (97.1 %) and 19 pa-
tients (27.9 %), respectively, in this study. Postoperative
complications of published series for PBC are listed in
Table 5 [21]. According to the report by Skirving and
Dan [19], facial numbness occurred in 89 % of 496 pa-
tients, symptomatic dysesthesias in 3.8 %, and symptom-
atic masseter weakness in 3.4 %. Abdennebi et al. [24]
reported complications including dysesthesia (10.6 % of
the 150 patients), transient masticatory weakness (6.6
%), and diminished corneal reflex (2.6 %). Chen et al.
[25] reported that 100 % of the patients experienced fa-
cial numbness after PBC, and 18.8 % suffered mastica-
tory weakness. In our study, the rate of masseter muscle
weakness was higher than those previously reported [19,
24, 25], and it might be related to our longer compression
time (3–8 min, mean 6.2 min). In Skirving and Dan’s
report [19], the duration of compression was between 2
and 7 min. Baabor and Perez-Limonte [22] reported that
the compression time was between 1.3 and 3 min.
One patient in our study suffered diplopia secondary
to abducens nerve weakness and recovered within 4
months. Several studies have reported that diplopia was
a relatively rare complication [19–23], and all of them
recovered within 3–6 months. As it could be seen, all
cases of diplopia described in the published studied weretransient. It is unlike what happens in radiofrequency
rhizotomy, which might cause permanent diplopia [21].
Conclusions
In this study, the authors reviewed data on a cohort of
patient older than 80 years. The PBC procedure has ad-
vantages in that it is minimally invasive, safe, effective,
and could be performed under general anesthesia. This
makes it an optimized choice for elderly patients or
physically unstable patients which present some special
risks for MVD.
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